vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and LCNB CORP (LCNB). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $23.9M, roughly 2.0× LCNB CORP). LCNB CORP runs the higher net margin — 23.7% vs -4.8%, a 28.5% gap on every dollar of revenue. On growth, LCNB CORP posted the faster year-over-year revenue change (5.1% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $33.4M). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
IRWD vs LCNB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $23.9M |
| Net Profit | $-2.3M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 29.2% |
| Net Margin | -4.8% | 23.7% |
| Revenue YoY | -47.3% | 5.1% |
| Net Profit YoY | -200.9% | -7.6% |
| EPS (diluted) | $0.01 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $23.9M | ||
| Q3 25 | $122.1M | $23.8M | ||
| Q2 25 | $85.2M | $22.8M | ||
| Q1 25 | $41.1M | $21.5M | ||
| Q4 24 | $90.5M | $22.7M | ||
| Q3 24 | $91.6M | $21.4M | ||
| Q2 24 | $94.4M | $19.3M | ||
| Q1 24 | $74.9M | $17.8M |
| Q4 25 | $-2.3M | $5.7M | ||
| Q3 25 | $40.1M | $6.9M | ||
| Q2 25 | $23.6M | $5.9M | ||
| Q1 25 | $-37.4M | $4.6M | ||
| Q4 24 | $2.3M | $6.1M | ||
| Q3 24 | $3.6M | $4.5M | ||
| Q2 24 | $-860.0K | $925.0K | ||
| Q1 24 | $-4.2M | $1.9M |
| Q4 25 | 14.3% | 29.2% | ||
| Q3 25 | 61.8% | 35.6% | ||
| Q2 25 | 53.2% | 31.6% | ||
| Q1 25 | -70.7% | 25.6% | ||
| Q4 24 | 34.8% | 32.9% | ||
| Q3 24 | 28.0% | 24.9% | ||
| Q2 24 | 26.5% | 4.9% | ||
| Q1 24 | 14.7% | 12.5% |
| Q4 25 | -4.8% | 23.7% | ||
| Q3 25 | 32.8% | 29.1% | ||
| Q2 25 | 27.7% | 26.0% | ||
| Q1 25 | -90.9% | 21.4% | ||
| Q4 24 | 2.5% | 27.0% | ||
| Q3 24 | 4.0% | 21.2% | ||
| Q2 24 | -0.9% | 4.8% | ||
| Q1 24 | -5.6% | 10.7% |
| Q4 25 | $0.01 | $0.40 | ||
| Q3 25 | $0.23 | $0.49 | ||
| Q2 25 | $0.14 | $0.41 | ||
| Q1 25 | $-0.23 | $0.33 | ||
| Q4 24 | $0.03 | $0.44 | ||
| Q3 24 | $0.02 | $0.31 | ||
| Q2 24 | $-0.01 | $0.07 | ||
| Q1 24 | $-0.03 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $21.6M |
| Total DebtLower is stronger | — | $104.4M |
| Stockholders' EquityBook value | $-261.8M | $273.9M |
| Total Assets | $396.9M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $21.6M | ||
| Q3 25 | $140.4M | $35.9M | ||
| Q2 25 | $92.9M | $49.8M | ||
| Q1 25 | $108.5M | $37.7M | ||
| Q4 24 | $88.6M | $35.7M | ||
| Q3 24 | $88.2M | $39.4M | ||
| Q2 24 | $105.5M | $34.9M | ||
| Q1 24 | $121.5M | $33.0M |
| Q4 25 | — | $104.4M | ||
| Q3 25 | $199.5M | $104.7M | ||
| Q2 25 | $199.3M | $105.0M | ||
| Q1 25 | $199.2M | $104.6M | ||
| Q4 24 | $199.0M | $155.2M | ||
| Q3 24 | $198.8M | $155.7M | ||
| Q2 24 | $198.6M | $162.2M | ||
| Q1 24 | $398.3M | $162.6M |
| Q4 25 | $-261.8M | $273.9M | ||
| Q3 25 | $-264.2M | $269.9M | ||
| Q2 25 | $-308.2M | $263.5M | ||
| Q1 25 | $-334.1M | $258.7M | ||
| Q4 24 | $-301.3M | $253.0M | ||
| Q3 24 | $-311.3M | $253.2M | ||
| Q2 24 | $-321.7M | $245.2M | ||
| Q1 24 | $-330.5M | $233.7M |
| Q4 25 | $396.9M | $2.2B | ||
| Q3 25 | $396.1M | $2.2B | ||
| Q2 25 | $342.9M | $2.3B | ||
| Q1 25 | $327.2M | $2.3B | ||
| Q4 24 | $350.9M | $2.3B | ||
| Q3 24 | $389.5M | $2.3B | ||
| Q2 24 | $395.6M | $2.4B | ||
| Q1 24 | $438.8M | $2.3B |
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $34.4M |
| Free Cash FlowOCF − Capex | $74.6M | $33.4M |
| FCF MarginFCF / Revenue | 156.3% | 140.2% |
| Capex IntensityCapex / Revenue | 0.0% | 4.0% |
| Cash ConversionOCF / Net Profit | — | 6.08× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $54.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $34.4M | ||
| Q3 25 | $47.6M | $14.0M | ||
| Q2 25 | $-15.1M | $5.5M | ||
| Q1 25 | $20.0M | $2.2M | ||
| Q4 24 | $15.2M | $93.2M | ||
| Q3 24 | $9.9M | $11.9M | ||
| Q2 24 | $33.5M | $54.9M | ||
| Q1 24 | $45.0M | $-11.9M |
| Q4 25 | $74.6M | $33.4M | ||
| Q3 25 | $47.6M | $13.7M | ||
| Q2 25 | $-15.1M | $5.2M | ||
| Q1 25 | $19.9M | $2.1M | ||
| Q4 24 | — | $89.4M | ||
| Q3 24 | $9.9M | $10.5M | ||
| Q2 24 | $33.4M | $53.8M | ||
| Q1 24 | $44.9M | $-12.8M |
| Q4 25 | 156.3% | 140.2% | ||
| Q3 25 | 39.0% | 57.4% | ||
| Q2 25 | -17.7% | 23.0% | ||
| Q1 25 | 48.4% | 10.0% | ||
| Q4 24 | — | 394.0% | ||
| Q3 24 | 10.8% | 49.0% | ||
| Q2 24 | 35.4% | 278.6% | ||
| Q1 24 | 60.0% | -71.8% |
| Q4 25 | 0.0% | 4.0% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.0% | 16.7% | ||
| Q3 24 | 0.0% | 6.7% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.1% | 4.8% |
| Q4 25 | — | 6.08× | ||
| Q3 25 | 1.19× | 2.02× | ||
| Q2 25 | -0.64× | 0.92× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | 6.74× | 15.23× | ||
| Q3 24 | 2.71× | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
